<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[support@nuaxia.com]]></title><description><![CDATA[nuaxia]]></description><link>https://www.nuaxia.com/blog</link><generator>RSS for Node</generator><lastBuildDate>Fri, 24 Jul 2026 05:36:06 GMT</lastBuildDate><atom:link href="https://www.nuaxia.com/ko/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Ottobock Acquires Fesia Technology to Expand Neurorehabilitation Portfolio]]></title><description><![CDATA[The acquisition adds functional electrical stimulation technology to Ottobock’s neuro-orthotics offering, strengthening its position in the growing neurological devices market.]]></description><link>https://www.nuaxia.com/pt/post/ottobock-acquires-fesia-technology-to-expand-neurorehabilitation-portfolio-7</link><guid isPermaLink="false">6a6239c9e168dd1a50c74a88</guid><pubDate>Thu, 23 Jul 2026 16:00:12 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8bf18b_623dce35421b4d1e97b286d1383e36e3~mv2.jpg/v1/fit/w_1000,h_720,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>nuaxia</dc:creator></item><item><title><![CDATA[Ottobock Acquires Fesia Technology to Expand Neurorehabilitation Portfolio]]></title><description><![CDATA[The acquisition adds functional electrical stimulation technology to Ottobock’s neuro-orthotics offering, strengthening its position in the growing neurological devices market.]]></description><link>https://www.nuaxia.com/ja/post/ottobock-acquires-fesia-technology-to-expand-neurorehabilitation-portfolio-6</link><guid isPermaLink="false">6a6239c67ea166f54a5075bd</guid><pubDate>Thu, 23 Jul 2026 16:00:10 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8bf18b_623dce35421b4d1e97b286d1383e36e3~mv2.jpg/v1/fit/w_1000,h_720,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>nuaxia</dc:creator></item><item><title><![CDATA[Ottobock Acquires Fesia Technology to Expand Neurorehabilitation Portfolio]]></title><description><![CDATA[The acquisition adds functional electrical stimulation technology to Ottobock’s neuro-orthotics offering, strengthening its position in the growing neurological devices market.]]></description><link>https://www.nuaxia.com/it/post/ottobock-acquires-fesia-technology-to-expand-neurorehabilitation-portfolio-5</link><guid isPermaLink="false">6a6239c2c2b482790d78b101</guid><pubDate>Thu, 23 Jul 2026 16:00:08 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8bf18b_623dce35421b4d1e97b286d1383e36e3~mv2.jpg/v1/fit/w_1000,h_720,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>nuaxia</dc:creator></item><item><title><![CDATA[Ottobock Acquires Fesia Technology to Expand Neurorehabilitation Portfolio]]></title><description><![CDATA[The acquisition adds functional electrical stimulation technology to Ottobock’s neuro-orthotics offering, strengthening its position in the growing neurological devices market.]]></description><link>https://www.nuaxia.com/fr/post/ottobock-acquires-fesia-technology-to-expand-neurorehabilitation-portfolio-4</link><guid isPermaLink="false">6a6239c09407ebe39fcc846d</guid><pubDate>Thu, 23 Jul 2026 16:00:05 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8bf18b_623dce35421b4d1e97b286d1383e36e3~mv2.jpg/v1/fit/w_1000,h_720,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>nuaxia</dc:creator></item><item><title><![CDATA[Ottobock Acquires Fesia Technology to Expand Neurorehabilitation Portfolio]]></title><description><![CDATA[The acquisition adds functional electrical stimulation technology to Ottobock’s neuro-orthotics offering, strengthening its position in the growing neurological devices market.]]></description><link>https://www.nuaxia.com/es/post/ottobock-acquires-fesia-technology-to-expand-neurorehabilitation-portfolio-3</link><guid isPermaLink="false">6a6239bc6185ff3d2f11d463</guid><pubDate>Thu, 23 Jul 2026 16:00:03 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8bf18b_623dce35421b4d1e97b286d1383e36e3~mv2.jpg/v1/fit/w_1000,h_720,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>nuaxia</dc:creator></item><item><title><![CDATA[Ottobock Acquires Fesia Technology to Expand Neurorehabilitation Portfolio]]></title><description><![CDATA[The acquisition adds functional electrical stimulation technology to Ottobock’s neuro-orthotics offering, strengthening its position in the growing neurological devices market.]]></description><link>https://www.nuaxia.com/de/post/ottobock-acquires-fesia-technology-to-expand-neurorehabilitation-portfolio-2</link><guid isPermaLink="false">6a6239ba8c1eb47f139866b8</guid><pubDate>Thu, 23 Jul 2026 16:00:01 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8bf18b_623dce35421b4d1e97b286d1383e36e3~mv2.jpg/v1/fit/w_1000,h_720,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>nuaxia</dc:creator></item><item><title><![CDATA[Ottobock Acquires Fesia Technology to Expand Neurorehabilitation Portfolio]]></title><description><![CDATA[The acquisition adds functional electrical stimulation technology to Ottobock’s neuro-orthotics offering, strengthening its position in the growing neurological devices market.]]></description><link>https://www.nuaxia.com/zh/post/ottobock-acquires-fesia-technology-to-expand-neurorehabilitation-portfolio-1</link><guid isPermaLink="false">6a6239cda35450685a624c88</guid><pubDate>Thu, 23 Jul 2026 15:59:56 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8bf18b_623dce35421b4d1e97b286d1383e36e3~mv2.jpg/v1/fit/w_1000,h_720,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>nuaxia</dc:creator></item><item><title><![CDATA[VB Spine Expands Surgical Navigation Portfolio with Augmedics CT-Fluoro Technology Deal]]></title><description><![CDATA[The agreement adds advanced imaging capabilities to the xvision Spine System platform, supporting broader adoption of augmented reality navigation in spinal procedures.]]></description><link>https://www.nuaxia.com/pt/post/vb-spine-expands-surgical-navigation-portfolio-with-augmedics-ct-fluoro-technology-deal-7</link><guid isPermaLink="false">6a62393500ee0bc71a278422</guid><pubDate>Thu, 23 Jul 2026 15:55:52 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8bf18b_623dce35421b4d1e97b286d1383e36e3~mv2.jpg/v1/fit/w_1000,h_720,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>nuaxia</dc:creator></item><item><title><![CDATA[VB Spine Expands Surgical Navigation Portfolio with Augmedics CT-Fluoro Technology Deal]]></title><description><![CDATA[The agreement adds advanced imaging capabilities to the xvision Spine System platform, supporting broader adoption of augmented reality navigation in spinal procedures.]]></description><link>https://www.nuaxia.com/ja/post/vb-spine-expands-surgical-navigation-portfolio-with-augmedics-ct-fluoro-technology-deal-6</link><guid isPermaLink="false">6a623933ad9184c612d7faf5</guid><pubDate>Thu, 23 Jul 2026 15:55:50 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8bf18b_623dce35421b4d1e97b286d1383e36e3~mv2.jpg/v1/fit/w_1000,h_720,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>nuaxia</dc:creator></item><item><title><![CDATA[VB Spine Expands Surgical Navigation Portfolio with Augmedics CT-Fluoro Technology Deal]]></title><description><![CDATA[The agreement adds advanced imaging capabilities to the xvision Spine System platform, supporting broader adoption of augmented reality navigation in spinal procedures.]]></description><link>https://www.nuaxia.com/it/post/vb-spine-expands-surgical-navigation-portfolio-with-augmedics-ct-fluoro-technology-deal-5</link><guid isPermaLink="false">6a62392f7ea166f54a50752f</guid><pubDate>Thu, 23 Jul 2026 15:55:48 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8bf18b_623dce35421b4d1e97b286d1383e36e3~mv2.jpg/v1/fit/w_1000,h_720,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>nuaxia</dc:creator></item><item><title><![CDATA[VB Spine Expands Surgical Navigation Portfolio with Augmedics CT-Fluoro Technology Deal]]></title><description><![CDATA[The agreement adds advanced imaging capabilities to the xvision Spine System platform, supporting broader adoption of augmented reality navigation in spinal procedures.]]></description><link>https://www.nuaxia.com/fr/post/vb-spine-expands-surgical-navigation-portfolio-with-augmedics-ct-fluoro-technology-deal-4</link><guid isPermaLink="false">6a62392cedd1a32780007e30</guid><pubDate>Thu, 23 Jul 2026 15:55:46 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8bf18b_623dce35421b4d1e97b286d1383e36e3~mv2.jpg/v1/fit/w_1000,h_720,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>nuaxia</dc:creator></item><item><title><![CDATA[VB Spine Expands Surgical Navigation Portfolio with Augmedics CT-Fluoro Technology Deal]]></title><description><![CDATA[The agreement adds advanced imaging capabilities to the xvision Spine System platform, supporting broader adoption of augmented reality navigation in spinal procedures.]]></description><link>https://www.nuaxia.com/es/post/vb-spine-expands-surgical-navigation-portfolio-with-augmedics-ct-fluoro-technology-deal-3</link><guid isPermaLink="false">6a62392900ee0bc71a278410</guid><pubDate>Thu, 23 Jul 2026 15:55:43 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8bf18b_623dce35421b4d1e97b286d1383e36e3~mv2.jpg/v1/fit/w_1000,h_720,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>nuaxia</dc:creator></item><item><title><![CDATA[VB Spine Expands Surgical Navigation Portfolio with Augmedics CT-Fluoro Technology Deal]]></title><description><![CDATA[The agreement adds advanced imaging capabilities to the xvision Spine System platform, supporting broader adoption of augmented reality navigation in spinal procedures.]]></description><link>https://www.nuaxia.com/de/post/vb-spine-expands-surgical-navigation-portfolio-with-augmedics-ct-fluoro-technology-deal-2</link><guid isPermaLink="false">6a6239246185ff3d2f11d3da</guid><pubDate>Thu, 23 Jul 2026 15:55:41 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8bf18b_623dce35421b4d1e97b286d1383e36e3~mv2.jpg/v1/fit/w_1000,h_720,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>nuaxia</dc:creator></item><item><title><![CDATA[VB Spine Expands Surgical Navigation Portfolio with Augmedics CT-Fluoro Technology Deal]]></title><description><![CDATA[The agreement adds advanced imaging capabilities to the xvision Spine System platform, supporting broader adoption of augmented reality navigation in spinal procedures.]]></description><link>https://www.nuaxia.com/zh/post/vb-spine-expands-surgical-navigation-portfolio-with-augmedics-ct-fluoro-technology-deal-1</link><guid isPermaLink="false">6a62393a9407ebe39fcc83f1</guid><pubDate>Thu, 23 Jul 2026 15:55:36 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8bf18b_623dce35421b4d1e97b286d1383e36e3~mv2.jpg/v1/fit/w_1000,h_720,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>nuaxia</dc:creator></item><item><title><![CDATA[NICE Recommends First Non-Invasive Endometriosis Diagnostic Tools for NHS Use]]></title><description><![CDATA[EndoSure and Ziwig Endotest will be introduced as complementary diagnostic options, aiming to reduce delays in diagnosis for millions of women affected by endometriosis.]]></description><link>https://www.nuaxia.com/pt/post/nice-recommends-first-non-invasive-endometriosis-diagnostic-tools-for-nhs-use-7</link><guid isPermaLink="false">6a62389e49285c3efe6231d9</guid><pubDate>Thu, 23 Jul 2026 15:53:39 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8bf18b_816c8c31948e46088eb49f9e3ad95411~mv2.jpg/v1/fit/w_1000,h_720,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>nuaxia</dc:creator></item><item><title><![CDATA[NICE Recommends First Non-Invasive Endometriosis Diagnostic Tools for NHS Use]]></title><description><![CDATA[EndoSure and Ziwig Endotest will be introduced as complementary diagnostic options, aiming to reduce delays in diagnosis for millions of women affected by endometriosis.]]></description><link>https://www.nuaxia.com/ja/post/nice-recommends-first-non-invasive-endometriosis-diagnostic-tools-for-nhs-use-6</link><guid isPermaLink="false">6a623899ad9184c612d7fa6b</guid><pubDate>Thu, 23 Jul 2026 15:53:37 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8bf18b_816c8c31948e46088eb49f9e3ad95411~mv2.jpg/v1/fit/w_1000,h_720,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>nuaxia</dc:creator></item><item><title><![CDATA[NICE Recommends First Non-Invasive Endometriosis Diagnostic Tools for NHS Use]]></title><description><![CDATA[EndoSure and Ziwig Endotest will be introduced as complementary diagnostic options, aiming to reduce delays in diagnosis for millions of women affected by endometriosis.]]></description><link>https://www.nuaxia.com/it/post/nice-recommends-first-non-invasive-endometriosis-diagnostic-tools-for-nhs-use-5</link><guid isPermaLink="false">6a62389449285c3efe6231cb</guid><pubDate>Thu, 23 Jul 2026 15:53:33 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8bf18b_816c8c31948e46088eb49f9e3ad95411~mv2.jpg/v1/fit/w_1000,h_720,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>nuaxia</dc:creator></item><item><title><![CDATA[NICE Recommends First Non-Invasive Endometriosis Diagnostic Tools for NHS Use]]></title><description><![CDATA[EndoSure and Ziwig Endotest will be introduced as complementary diagnostic options, aiming to reduce delays in diagnosis for millions of women affected by endometriosis.]]></description><link>https://www.nuaxia.com/fr/post/nice-recommends-first-non-invasive-endometriosis-diagnostic-tools-for-nhs-use-4</link><guid isPermaLink="false">6a62388fa35450685a624b76</guid><pubDate>Thu, 23 Jul 2026 15:53:30 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8bf18b_816c8c31948e46088eb49f9e3ad95411~mv2.jpg/v1/fit/w_1000,h_720,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>nuaxia</dc:creator></item><item><title><![CDATA[NICE Recommends First Non-Invasive Endometriosis Diagnostic Tools for NHS Use]]></title><description><![CDATA[EndoSure and Ziwig Endotest will be introduced as complementary diagnostic options, aiming to reduce delays in diagnosis for millions of women affected by endometriosis.]]></description><link>https://www.nuaxia.com/es/post/nice-recommends-first-non-invasive-endometriosis-diagnostic-tools-for-nhs-use-3</link><guid isPermaLink="false">6a6238891ca5bdf308a1c525</guid><pubDate>Thu, 23 Jul 2026 15:53:27 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8bf18b_816c8c31948e46088eb49f9e3ad95411~mv2.jpg/v1/fit/w_1000,h_720,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>nuaxia</dc:creator></item><item><title><![CDATA[NICE Recommends First Non-Invasive Endometriosis Diagnostic Tools for NHS Use]]></title><description><![CDATA[EndoSure and Ziwig Endotest will be introduced as complementary diagnostic options, aiming to reduce delays in diagnosis for millions of women affected by endometriosis.]]></description><link>https://www.nuaxia.com/de/post/nice-recommends-first-non-invasive-endometriosis-diagnostic-tools-for-nhs-use-2</link><guid isPermaLink="false">6a6238827ea166f54a50747b</guid><pubDate>Thu, 23 Jul 2026 15:53:26 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8bf18b_816c8c31948e46088eb49f9e3ad95411~mv2.jpg/v1/fit/w_1000,h_720,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>nuaxia</dc:creator></item></channel></rss>